Hallo! Tracked shipping to Netherlands with Delivery Duty Paid for just €7 

Ship to
Netherlands
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Biosimilars and Interchangeable Biologics: Strategic Elements
Type
Physical Book
Author
Publisher
Language
English
Pages
646
Format
Paperback
ISBN13
9781138775503
Edition No.
1
Categories

Biosimilars and Interchangeable Biologics: Strategic Elements

Sarfaraz K. Niazi (Author) · CRC Press · Paperback

Biosimilars and Interchangeable Biologics: Strategic Elements - Niazi, Sarfaraz K.

New Book Imported to Netherlands
Delivery: 15 Oct - 22 Oct Shipping: 14 to 18 business days.
€ 184,52
Import costs and 9% BTW included in the price ✅
€ 184,52

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Biosimilars and Interchangeable Biologics: Strategic Elements"

What's the Deal with Biosimilars?Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Strategic Elements explores the strategic planning side of biosimilar drugs and targets issues surrounding biosimilars that are linked to legal matters. This includes principal patents and intellectual property, regulatory pathways, and concerns about affordability on a global scale. It addresses the complexity of biosimilar products, and it discusses the utilization of biosimilars and related biological drugs in expanding world markets.Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume examines the science, technology, finance, legality, ethics, and politics of biosimilar drugs. It considers strategic planning elements that include an overall understanding of the history and the current status of the art and science of biosimilars, and it provides detailed descriptions of the legal, regulatory, and commercial characteristics. The book also presents a global strategy on how to build, take to market, and manage the next generation of biosimilars throughout their life cycle.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews